GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out in collaboration between the University of Eastern Finland, Karolinska Institutet in Stockholm and Griffith University in Australia.
The Unexpected Mental Health Effect of GLP-1 Medications
The study findings may spark treatment innovations for depression and anxiety.
Ozempic in Schizophrenia; Psychiatrist Talks Euthanasia; New Opioid Threat
(MedPage Today) — In overweight, prediabetic schizophrenia patients on second-generation antipsychotics, semaglutide (Ozempic) significantly improved insulin sensitivity, fasting glucose, and weight. (Diabetes Care)
Experts weighed in on whether…
Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s
New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop taking these drugs, they not only regain weight, but, according to a new study, they also incur increased risk of heart attack, stroke, and death compared to staying on the medication.
Type 2 Diabetes Risk Varies Widely in Young Adults. How GLP-1s Can Help
New research highlights a need for earlier, more tailored interventions to prevent type 2 diabetes in young adults with prediabetes. Klaus Vedfelt/Getty Images
Researchers found that type 2 diabetes risk varies among adults ages 18 to 40.
Those with high fasting glucose, especially if they qualified for GLP-1 treatment, had higher risk.
GLP-1 drugs and 8 healthy lifestyle habits may lower cardiovascular risk
How do GLP-1s affect bone health? New studies investigate
Could GLP-1 drugs cut the risk of complications after a heart attack?
Wegovy users may have 5 times risk of vision loss than those on Ozempic
